Conversely, overexpression of NEP in AD mouse models using genetic, viral, and pharmacological approaches leads to decreased cerebral Aβ levels [28, 87], inhibition of plaque formation [80], and enhanced cognitive function [88] and life expectancy [30, 36, 40, 89–92]. This evidence concerns the gene MME and Alzheimer disease.